Lamivudine-induced muscle mitochondrial toxicity [2]

Digestive and Liver Disease

Volumn 34, Issue 5, 2002, Pages 384-385

  Ojetti, V ^a   Gasharrini, A ^a   Migneco, A ^a   Fiore, R ^a   Santoliquido, A ^a   De Martini, D ^a   Agnes, S ^a   Gentiloni Silveri, N ^a   Pole, P ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE; CYCLOSPORIN; IMMUNOGLOBULIN; LACTIC ACID; LAMIVUDINE; METHYLPREDNISOLONE; MYOGLOBIN; ANTIVIRUS AGENT;

ADULT; CASE REPORT; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; ENZYME ACTIVITY; GRAFT REJECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER TRANSPLANTATION; MALE; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE MITOCHONDRION; MUSCLE WEAKNESS; MYALGIA; PARESTHESIA; TREATMENT OUTCOME; VIRUS REPLICATION; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; MITOCHONDRIAL MYOPATHY;

ANTIVIRAL AGENTS; HEPATITIS B; HUMANS; LAMIVUDINE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MITOCHONDRIAL MYOPATHIES;

EID: 0035986241     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1590-8658(02)80136-0     Document Type: Letter

References (5)

1. Severe clinical course of the novo hepatitis B infection after liver transplantation
2. Therapy of chronic viral hepatitis: A critical view
3. Mitochondrial dysfunction and neuromuscular disease
4. Rhabdomyolysis in antiretroviral therapy with Lamivudin
5. Effect of lamivudine on morphology and function of mitochondria in patients with chronic hepatitis B